Series B startup

Who invested in ImmunoBiome

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$18Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $18MSept 2021
Investors
3
See who backed them

The rounds

  1. Sept 2021

Everyone who backed them

DSC InvestmentVC firm1round
Aju IB InvestmentVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists ImmunoBiome as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

POSTECH HoldingsAcceleratorPer its own site

Quick answers about ImmunoBiome

Who invested in ImmunoBiome?

ImmunoBiome's investors include Korea Investment Partners, DSC Investment and Aju IB Investment.

How much has ImmunoBiome raised?

ImmunoBiome has raised $18M across 1 round since 2021.

When did ImmunoBiome last raise?

ImmunoBiome's most recent round was a Series B of $18M in Sept 2021.

What was ImmunoBiome's biggest round?

Its most recent round, $18M in Sept 2021, is also its largest on record.

Who backed ImmunoBiome first?

ImmunoBiome's first round on record, in Sept 2021, was backed by Korea Investment Partners, DSC Investment and Aju IB Investment.

What stage is ImmunoBiome at?

ImmunoBiome's latest named round is a Series B, in Sept 2021.

Companies like ImmunoBiome

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.